Results 171 to 180 of about 79,407 (254)

Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study. [PDF]

J Korean Med Sci
Choi HB, Kim JY, Yoo JJ, Kim SG, Kim YS.
europepmc   +1 more source

Treatment Persistence and Switch Among Medicare-Insured People with HIV and Gaps in Care. [PDF]

Infect Dis Ther
Li S, Mordi U, Christoph MJ, Guo H, Gilbertson DT, Cui T, Lim T, Prata Menezes N, Zachry W, Tien PC.   +9 more
europepmc   +1 more source

Beyond DXA: Trabecular Bone Score, Quantitative Ultrasound and Bone Turnover Markers for Morphometric Vertebral Fracture Assessment in People Living with HIV. [PDF]

Diagnostics (Basel)
Razvan DV, Rosca O, Bogdan IG, Stanga L, Laitin SMD, Vlad A.   +5 more
europepmc   +1 more source

Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial. [PDF]

Hepatol Commun
Tabataba Vakili S, Hirode G, Zahoor A, Saunthar A, Feld JB, Hansen BE, Syeda A, Janssen HLA, Kukreti V, Kuruvilla J, Prica A, Cheung M, Buckstein R, Hicks L, Coffin CS, Street LE, Disperati P, Chan KK, Crump M, Feld JJ.   +19 more
europepmc   +1 more source

Investigation of the long-term effects of high-potency antiviral agents on aspartate aminotransferase-to-platelet ratio index and fibrosis index based on four factors: five-year outcomes in hepatitis B e-antigen-negative chronic hepatitis B patients. [PDF]

Rev Assoc Med Bras (1992)
Arslan M, Cavnar AM, Çetin Ş.
europepmc   +1 more source

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. [PDF]

AIDS Res Treat
Pérez-Calvo F, Jover-Diaz F, Delgado-Sánchez E, Peris-García J, Bernabéu-Martínez MÁ.   +4 more
europepmc   +1 more source

Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B. [PDF]

AIDS
Dieterich DT, Brunet L, Hsu RK, Mounzer K, Pierone G, Wohlfeiler MB, Fusco JS, Dunbar MS, Gruber J, Yee LJ, Frenette C, Lim T, Fusco GP.   +12 more
europepmc   +1 more source

Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapy. [PDF]

Viruses
Yılmaz Nakir İ, Çağlar B, Zerdali E, Karaduman RG, Pehlivanoğlu F.   +4 more
europepmc   +1 more source

Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation. [PDF]

World J Gastrointest Oncol
Xu BG, Zhang X, Liu F, Li FH, Zhang X, Xiang HL, Liang J.   +6 more
europepmc   +1 more source

Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs. [PDF]

Arch Virol
Sato Y, Doi K, Inoue J, Ninomiya M, Tsuruoka M, Sato K, Onuki M, Sawahashi S, Ouchi K, Watanabe K, Niitsuma H, Masamune A.   +11 more
europepmc   +1 more source